Skip to content

DMAA

Overview

TripSit

Also known as methylhexanamine, this sympathetomimetic drug was developed as a nasal decongestant by Eli Lilly in the 1940s. It has been used as a weight loss aid and missold as a dietary supplement and component of some energy drinks. Carries a risk of heart attack, stroke and other life-threatening cardiovascular issues.

Sources & licencesTripSit

TripSit material is used non-commercially with attribution and a link to the source. Where combination information is shown, it is a quick reference and should be checked with further individual research.

Snapshot
Bundled snapshot
Last data refresh

Fracton stores and reformats source data for local, offline display. These source projects do not endorse Fracton.